课题基金 / 基金详情

Apoptosis of helper T cells via the costimulatory molecules OX40 stimulated by gp34

Apoptosis of helper T cells via the costimulatory molecules OX40 stimulated by gp34
gp34 刺激的共刺激分子 OX40 导致辅助 T 细胞凋亡
批准号:
14599010
负责人:
TANAKA Yuetsu
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

TANAKA Yuetsu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
OX40 belongs to TNF receptor(TNF-R) super family and plays an important role in survival of antigen-pecific CD4^+ T cells. We have previously reported that the individual stimulation of OX40 or TNF-R by respective ligands of HIV-1-latently infected ACH-2/OX40 cells results in the activation of HIV-1 production via the NF-kB pathway. In the present study, we examined the effect of dual stimulation by OX40L and TNF on HIV-1 activation. In contrast to individual stimulation, HIV-1 production was severely interrupted by the dual stimulation, which was reversed by anti-OX40L antibody. Similar effects were also observed in other OX40-expressing, HIV-1 productively-chronically-and acutely-infected cells, Molt4/IIIB, U1 and Molt4, respectively. Microscopic observation of cell morphology and Annexin-V staining showed that the double-stimulated cells rapidly became apoptotic. The dual stimulation also induced cell death in T cell lines that were not infected with HIV-1(Molt-4/OX40,CEM/OX40 and Jurkat/OX40). In contrast, two promonocytic cell lines(U937/OX40 and THP-1/OX40) were relatively resistant, and a B cell line(BJAB/OX40) was completely resistant to the dual stimulation. A broad caspase inhibitor, Z-VAD-FMK, significantly reduced the death of Molt-4/OX40 cells. These results suggest a new biological role of OX40 in controlling not only HIV-1 production but also the fate of CD4^+ T cells in infection and inflammatory environments.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Seko Y, Ishiyama S, Tanaka Y et al.: "Expression of tumor necrosis factor ligand superfamily costimulatory molecules CD27L,CD30L,OX40L and 4-1BBL in the heart of patients with acute myocarditis and dilated cardiomyppathy."Cardiovasc Pathol.. 11. 166-170 (
Seko Y、Ishiyama S、Tanaka Y 等人:“肿瘤坏死因子配体超家族共刺激分子 CD27L、CD30L、OX40L 和 4-1BBL 在急性心肌炎和扩张型心肌病患者心脏中的表达。”Cardiovasc Pathol.. 11。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsumura Y, Hattori T, Tanaka Y, 他5名: "Expression of CD134 and CD134 ligand in lesional and nonlesional psoriatic skin"Arch.Dermatol.Res.. 294. 563-566 (2003)
Matsumura Y、Hattori T、Tanaka Y 和其他 5 人:“CD134 和 CD134 配体在病变和非病变银屑病皮肤中的表达”Arch.Dermatol.Res.. 294. 563-566 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Seko Y, Ishiyama S, Tanaka Y, et al.: "Expression of tumor necrosis factor ligand superfamily costimulatory molecules CD27L, CD30L, OX40L and 4-1BBL in the heart of patients with acute myocarditis dilated cardiomyopathy."Cardiovasc Pathol.. 11. 166-170 (2
Seko Y、Ishiyama S、Tanaka Y 等人:“急性心肌炎扩张型心肌病患者心脏中肿瘤坏死因子配体超家族共刺激分子 CD27L、CD30L、OX40L 和 4-1BBL 的表达。”Cardiovasc Pathol.. 11。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Identification of a factor produced by anti-HIV CD4+ T cells induced by dendritic cell-based immunization in the hu-PBL-SCID mice
    • 批准号:
      16017288
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $9.6万
    • 财政年份:
      2004
    • 负责人:
      TANAKA Yuetsu
    • 依托单位:
    Identification of HTLV-1 neutralization epiotpe amino acid sequence its and application
    • 批准号:
      05670284
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1993
    • 负责人:
      TANAKA Yuetsu
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: